XML 48 R7.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 1,582 $ 1,694
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 410 399
Deferred income taxes 415 (202)
Stock-based compensation expense 137 134
(Gain) on sale of property and equipment (62) 0
Other (3) 23
Changes in assets and liabilities, net of effects of businesses acquired:    
Trade accounts receivable, current (322) (166)
Other current and noncurrent assets 1 (512)
Accounts payable (35) (29)
Deferred revenues, current and noncurrent (64) (56)
Other current and noncurrent liabilities (34) (81)
Net cash provided by operating activities 2,025 1,204
Cash flows from investing activities:    
Purchases of property and equipment (211) (214)
Proceeds from sale of property and equipment 70 0
Proceeds from maturity of held-to-maturity investment securities 0 3
Purchases of other investments (17) (1)
Proceeds from maturity or sale of other investments 3 260
Payments for business combinations, net of cash acquired 0 (1,615)
Net cash (used in) investing activities (155) (1,567)
Cash flows from financing activities:    
Issuance of common stock under stock-based compensation plans 46 49
Repurchases of common stock (1,040) (451)
Repayment of Term Loan borrowings and earnout and finance lease obligations (32) (61)
Proceeds from borrowings under the revolving credit facility 0 600
Repayment of notes outstanding under the revolving credit facility (300) 0
Dividends paid (459) (450)
Net cash (used in) financing activities (1,785) (313)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents 25 (28)
Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents 110 (704)
Cash, cash equivalents and restricted cash and cash equivalents beginning of year 2,231 2,717
Cash and cash equivalents, end of period $ 2,341 $ 2,013